Cleidocranial dysostosis is an uncommon genetic disorder characterized by anomalies in bone development, particularly impacting the collarbones and skull. This condition results from mutations in the RUNX2 gene, disrupting proper bone formation and ossification. Individuals with cleidocranial dysostosis often present with distinctive physical traits, including the absence or underdevelopment of collarbones, delayed closure of fontanelles (soft spots) in the skull, and dental irregularities such as delayed eruption of adult teeth and the presence of extra teeth.
Beyond affecting the skeletal system, cleidocranial dysostosis influences facial structure and dental health. Challenges in speech and motor development may arise, accompanied by difficulties in fine and gross motor skills. The management of cleidocranial dysostosis necessitates a multidisciplinary approach, integrating orthopedic care, dental interventions, and speech therapy. Timely monitoring and early interventions are critical to addressing the specific challenges associated with this genetic disorder.
Despite the intricacies of cleidocranial dysostosis, ongoing advancements in medical knowledge and treatment options contribute to enhanced outcomes. Support groups and patient advocacy efforts play a pivotal role in providing valuable information and fostering a supportive community for individuals and families affected by this genetic condition. In essence, cleidocranial dysostosis highlights the intricate relationship between genetics and bone development, emphasizing the need for holistic care to address its diverse manifestations and improve the overall well-being of individuals grappling with this condition.
Title : Evaluating hygienist follow up for head and neck oncology patients in secondary care: Results from a two cycle audit
Peter Basta, Newcastle Dental Hospital, United Kingdom
Title : Atypical facial pain unravelled
Christopher Turner, Spacemark Dental, United Kingdom
Title : New treatment of temporomandibular disorder through muscle balance and muscle regeneration by activation of quiescent muscle stem cells( satellite cells) with mitochondrial dynamics
Ki Ji Lee, National Reserach Foundation & Busan Medical University, Korea, Republic of
Title : MRONJ and ORN: Referral or management in primary care? Navigating guidelines in the context of long waiting lists
Alisha Sagar, NHS England, United Kingdom
Title : Managing the unexpected: An Insight into supernumerary teeth
Bahar Gharooni Dowrani, Guy's and St Thomas' NHS Foundation Trust, United Kingdom
Title : Laxative prescribing for post operative head and neck cancer patients at Derriford Hospital
Pui Sze Kylie Li, Cardiff and Vale University Health Board, United Kingdom